Industry News
Pharmaceutical Industry News
Drug-Resistant Bacteria Tied to Eyedrops Can Spread Person to Person
The C.D.C. traced deaths and cases of blindness to products imported from India. The agency said it was concerned that the bacteria could gain a foothold in the U.S.
Are Abortion Pills Safe? Here’s the Evidence.
The Times reviewed 101 studies of medication abortion, spanning continents and decades. All concluded that the pills are a safe method for terminating a pregnancy.
¿Cómo usar el Narcan, el aerosol para revertir sobredosis?
Esta versión de la naloxona, el fármaco que bloquea el efecto de los opiáceos en el cerebro, puede salvar vidas. Este es el modo de usarlo correctamente.
How to Use Narcan, the Overdose-Reversing Nasal Spray
The F.D.A.’s decision to allow the overdose-reversing nasal spray to be sold over the counter means it will become much more widely available.
How To Use Narcan to Save a Life
Narcan and other naloxone nasal sprays swiftly reverse an opioid overdose and are easy to use.
How to Use Narcan Nasal Spray
Narcan, a naloxone nasal spray, is now approved for over-the-counter sales and should be widely available by late summer. Experts say that these sprays can swiftly reverse an opioid overdose and are easy to use.
F.D.A. Approves Narcan for Over-the-Counter Sales
The nasal spray reverses opioid overdoses and public health officials hope that making it more widely available could save lives and reduce the nation’s high rates of drug fatalities.
Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles.
The Food and Drug Administration is expected this week to allow the overdose-reversal medication to be sold without a prescription, a step toward making it a common emergency tool.
The Adderall Shortage Reflects Bad Drug Policy
The D.E.A. is failing at its mission.
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
Rising Rate of Drug Shortages Is Framed as a National Security Threat
A Senate homeland security committee examined growing health care shortages amid reports of rationing within hospitals.
Sanofi Plans to Cut the Price of Insulin
The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment
While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.
What to Know About the Recent Eye Drop Recalls
Global Pharma recalled eye drops in February after they were tied to a drug-resistant bacteria strain linked to at least one death. Two more companies have since recalled eye drops.
Texas Judge Hears Case to End Federal Approval of Abortion Pill
The judge said he would decide soon whether to issue a preliminary injunction ordering the F.D.A. to withdraw its approval of the drug or wait for the full trial.
Biden Looks to Bolster Support Among Seniors With a Focus on Health Care
In a trip to Las Vegas, President Biden warned that Republicans would endanger popular programs like Social Security and Medicare.
Novo Nordisk Says It Will Slash the Price of Insulin
The company’s decision followed a similar move by its rival Eli Lilly this month.
How an Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugs
An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.
Judge in Abortion Pill Case Set Hearing but Sought to Delay Telling the Public
Saying he wanted safe and orderly proceedings, Judge Matthew J. Kacsmaryk asked lawyers not to disclose the hearing and planned to add it to the public case file only the evening before.
¿Podría el próximo fármaco de éxito conseguirse sin ratas de laboratorio?
Las alternativas a los ensayos con animales están ganando terreno.